U.S. FDA Set To Strengthen Inspections Of Chinese Drugmakers, Search For Adulterants In Aftermath Of Heparin Deaths – CDER Official

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.